IRST-AUSL Romagna breast cancer Conference: From molecular signature to clinical oncology
19.06.2025
CCCRN - Comprehensive Cancer Care and Research Network
Rimini, 19-20 giugno 2025
Centro Congressi SGR
Ruoli e responsabilità degli attori della ricerca clinica: gestione, conduzione e monitoraggio di uno studio clinico
07.05.2025
7 maggio - 28 maggio 2025 - 11 giugno 2025
FAD WEBINAR
Responsabile scientifico: Antonino Musolino
Empowering talks: state of the art and translational research in Breast and Ovarian Cancer
04.04.2025
4 aprile 2025
Star Hotel du Parc
Parma
L’evoluzione della medicina di precisione e personalizzata in oncologia: il ruolo della ricerca clinica accademica
28.03.2025
28-29 marzo 2025
HOTEL NH BOLOGNA DE LA GARE
Bologna
Impact of edoxaban-related adverse events in patients with cancer experiencing venous thromboembolism during antineoplastic therapy: Results of the phase IV EDOI study (GOIRC-05–2018)
09.02.2025
An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line
13.01.2025
Bridging bench to bedside: The evolution and impact of translational research in oncology. The experience of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)
13.01.2025
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years’ Follow-Up
09.01.2025
Adjuvant Pertuzumab and Trastuzumab in EarlyHuman Epidermal Growth Factor Receptor 2-PositiveBreast Cancer in the APHINITY Trial: Third InterimOverall Survival Analysis With Efficacy Update
08.01.2025
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study
07.01.2025
